Storia della carriera di Da Qing Cai
Precedenti posizioni note di Da Qing Cai
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Direttore/Membro del Consiglio | 20/08/2020 | 23/03/2023 |
| Independent Dir/Board Member | 20/08/2020 | 23/03/2023 | |
| BIONANO GENOMICS, INC. | Direttore/Membro del Consiglio | 01/08/2018 | 01/08/2019 |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 01/06/2016 | 01/03/2019 |
| BERRY GENOMICS CO.,LTD | Direttore/Membro del Consiglio | 01/07/2017 | 01/04/2018 |
Formazione di Da Qing Cai
| University of Science & Technology of China | Undergraduate Degree |
| Yale University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiche
Distribuzione geografica
| Cina | 5 |
| Stati Uniti | 4 |
Posizioni
| Director/Board Member | 4 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BERRY GENOMICS CO.,LTD | Health Technology |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Da Qing Cai
- Esperienza
